Skip to main content
TipRanks
Go Ultimate75% OFF

NeuroOne Medical Technologies (NMTC) Stock Price & Analysis

203 Followers

NMTC Stock Chart & Stats

$0.75$0.00(0.00%)
At close: 4:00 PM EST
$1$1.5$2Aug 24Sep 8Sep 21Oct 5Oct 19Nov 2Nov 16
Day’s Range
$0.75 - $0.81
52-Week Range
$0.75 - $6.12
Previous Close
$0.75
Volume
N/A
Average Volume (3M)
81.48K
Market Cap
$6.78M
Enterprise Value
$24.70M
Total Cash (Recent Filing)
$2.05M
Total Debt (Recent Filing)
$73.32K
Price to Earnings (P/E)
―
Beta
1.47
Next Earnings
Dec 16, 2026 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue Growth

Sustained product revenue growth indicates increasing adoption of NeuroOne’s neurodiagnostic and neurosurgical devices. Continued expansion from approximately $3.5M in FY2024 to $10.5M in preliminary FY2026 suggests improving commercial traction and a broader revenue base.

Purchase Order Visibility

The record purchase order provides meaningful forward visibility into near-term product demand and potential revenue conversion. Deliveries scheduled across the first half of FY2027 could support continued commercial momentum while strengthening the company’s position with healthcare customers.

Low Leverage

Minimal debt limits refinancing pressure and reduces the fixed financial burden while NeuroOne invests in commercial growth and product development. Although losses remain substantial, the low-leverage balance sheet provides more flexibility than a debt-heavy structure during the company’s scaling phase.

Bears Say

Severe Operating Losses

Very negative operating and net margins show that current revenue scale is not yet sufficient to cover the company’s cost base. Unless gross profit expands faster than operating expenses, revenue growth may continue without translating into sustainable earnings or internally funded expansion.

Worsening Cash Burn

The worsening cash deficit indicates that NeuroOne is consuming substantially more cash to operate as it grows. Persistent negative operating and free cash flow can constrain investment capacity and increase the company’s reliance on additional funding before profitability is reached.

Eroding Equity Cushion

The sharp decline in equity reflects the cumulative effect of ongoing losses and reduces the financial cushion available to support commercialization and development. Continued erosion could weaken resilience and make future capital needs more consequential even though current debt is minimal.

NeuroOne Medical Technologies News

NMTC FAQ

What was NeuroOne Medical Technologies’s price range in the past 12 months?
NeuroOne Medical Technologies lowest stock price was $0.75 and its highest was $6.12 in the past 12 months.
What is NeuroOne Medical Technologies’s market cap?
NeuroOne Medical Technologies’s market cap is $6.78M.
When is NeuroOne Medical Technologies’s upcoming earnings report date?
NeuroOne Medical Technologies’s next earnings report is estimated for Dec 16, 2026 (not yet confirmed), which is in 28 days.
How were NeuroOne Medical Technologies’s earnings last quarter?
NeuroOne Medical Technologies released its earnings results on Aug 19, 2026. The company reported -$0.23 earnings per share for the quarter.
Is NeuroOne Medical Technologies overvalued?
According to Wall Street analysts NeuroOne Medical Technologies’s price is currently Undervalued.
Does NeuroOne Medical Technologies pay dividends?
NeuroOne Medical Technologies does not currently pay dividends.
What is NeuroOne Medical Technologies’s EPS estimate?
NeuroOne Medical Technologies’s EPS estimate is -0.19.
How many shares outstanding does NeuroOne Medical Technologies have?
NeuroOne Medical Technologies has 9,105,763 shares outstanding.
What happened to NeuroOne Medical Technologies’s price movement after its last earnings report?
NeuroOne Medical Technologies reported an EPS of -$0.23 in its last earnings report. Following the earnings report the stock price went up 15.957%.
Which hedge fund is a major shareholder of NeuroOne Medical Technologies?
Hedge funds hold NeuroOne Medical Technologies shares: the largest hedge-fund position in NeuroOne Medical Technologies is 71,883,692 shares.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology